According to the nonpartisan Penn Wharton Budget Model, which tracks weekly Treasury data, total spending rose by 6.3%, or $156 billion, since Donald Trump took office, compared to the first four ...

With several members receiving termination letters and its webpage archived, public health experts believe the days are ...

Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).

The CDC’s ACIP updated guidance on pneumococcal vaccination, recommending a single dose of PCV for all adults aged 50 years and older.

Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be ...

Every year, during the last week of April, the world meets to observe World Immunization Week. This important initiative, led ...

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

Such a change would put the U.S. more in line with guidance in other countries and with the World Health Organization, which ...